Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$1.37B-21.2%-$1.13B-17.7%-$960.98M-18.3%-$812.06M-16.4%-$697.51M-16.2%
$8.43M+8.4%$7.78M+7.3%$7.25M+6.8%$6.79M+2.4%$6.63M+2.3%
$180.6M+52.6%$118.39M+10.5%$107.13M+10.3%$97.13M+10.3%$88.07M+11.2%
-$1.06B-17.8%-$897.74M-17.8%-$761.79M-11.2%-$684.9M-15.8%-$591.31M-6.1%
$14.26M-10.8%$15.99M+4.6%$15.29M-1.1%$15.46M+48.5%$10.41M+1.0%
$306.62M+160%$118.06M+134%-$349.73M+11.7%-$396.05M
$860.99M+38.2%$623.12M-44.9%$1.13B-6.4%$1.21B+26.0%$959.48M0.0%
-$1.07B-17.3%-$913.73M-17.6%-$777.08M-11.0%-$700.36M-16.4%-$601.72M-6.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Revolution Medicines, Inc. generate?
Revolution Medicines, Inc. (RVMD) generated -$1.1B in operating cash flow over the trailing twelve months.
What is Revolution Medicines, Inc.'s free cash flow?
After $14.3M of capital expenditures, Revolution Medicines, Inc.'s free cash flow was -$1.1B over the trailing twelve months, down 78.1% year over year.
Where does Revolution Medicines, Inc.'s cash flow data come from?
Every line is extracted from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.